ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in ImageneBio, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −2 vs. Q3 2023
- Shares held
- 32.4M
- +1.88M (+6.2%) vs. Q3 2023
- Total value
- $63.8M
- −$68.2M (−51.7%) vs. Q3 2023
- New holders
- 6
- 28 more added
- Sold out
- 8
- 12 more reduced
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 1,755 | $3.46K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,855 | $4.00K | 0.00% | −213−10.3% | Reduced |
| Legal & General Group Plc | 2,045 | $4.03K | 0.00% | 00.0% | Unchanged |
| Baystate Wealth Management LLC | 2,999 | $5.91K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 4,631 | $9.12K | 0.00% | +4,621+46,210.0% | Added |
| Tower Research Capital LLC (TRC) | 4,995 | $9.84K | 0.00% | +1,282+34.5% | Added |
| California State Teachers Retirement System | 5,095 | $10.0K | 0.00% | −385−7.0% | Reduced |
| Wells Fargo & Company | 9,476 | $18.7K | 0.00% | +3,346+54.6% | Added |
| Invesco Ltd. | 10,158 | $20.0K | 0.00% | +10,158 | New |
| Royal Bank of Canada | 10,911 | $21.0K | 0.00% | +6,629+154.8% | Added |
| New York State Common Retirement Fund | 14,992 | $29.5K | 0.00% | −70−0.5% | Reduced |
| American International Group, Inc. | 15,386 | $30.3K | 0.00% | +2,992+24.1% | Added |
| Susquehanna International Group, LLP | 20,170 | $39.7K | 0.00% | +20,170 | New |
| SG Americas Securities, LLC | 20,222 | $40.0K | 0.00% | +9,495+88.5% | Added |
| Acadian Asset Management LLC | 21,722 | $41.0K | 0.00% | +11,524+113.0% | Added |
| UBS Group AG | 21,090 | $41.5K | 0.00% | +7,430+54.4% | Added |
| Jane Street Group, LLC | 22,072 | $43.5K | 0.00% | +22,072 | New |
| JPMorgan Chase & Co | 22,329 | $44.0K | 0.00% | +5,851+35.5% | Added |
| Goldman Sachs Group Inc | 23,595 | $46.5K | 0.00% | +2,206+10.3% | Added |
| Virtu Financial LLC | 26,882 | $53.0K | 0.00% | +15,207+130.3% | Added |
| Rhumbline Advisers | 26,913 | $53.0K | 0.00% | +1,535+6.0% | Added |
| Cornercap Investment Counsel Inc | 36,157 | $71.2K | 0.01% | −1,087−2.9% | Reduced |
| Nuveen Asset Management, LLC | 36,322 | $71.6K | 0.00% | +3,299+10.0% | Added |
| Dimensional Fund Advisors LP | 38,633 | $76.3K | 0.00% | −46,982−54.9% | Reduced |
| Bank of America Corp | 49,982 | $98.5K | 0.00% | +20,206+67.9% | Added |
| Two Sigma Investments, LP | 50,933 | $100.3K | 0.00% | +29,204+134.4% | Added |
| Jacobs Levy Equity Management, Inc | 56,195 | $110.7K | 0.00% | −1,051−1.8% | Reduced |
| Morgan Stanley | 68,577 | $135.1K | 0.00% | +52,862+336.4% | Added |
| Bank of New York Mellon Corp | 69,239 | $136.4K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 85,946 | $169.3K | 0.00% | +16,212+23.2% | Added |
| Ensign Peak Advisors, Inc | 90,310 | $177.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 143,550 | $282.8K | 0.01% | +28,900+25.2% | Added |
| Citadel Advisors LLC | 178,177 | $351.0K | 0.00% | −28,560−13.8% | Reduced |
| Anson Funds Management LP | 209,315 | $412.4K | 0.09% | +209,315 | New |
| Vida Ventures Advisors, LLC | 225,192 | $443.6K | 0.53% | 00.0% | Unchanged |
| Northern Trust Corp | 238,572 | $470.0K | 0.00% | +40,560+20.5% | Added |
| Barclays PLC | 244,655 | $482.0K | 0.00% | +38,110+18.5% | Added |
| Adage Capital Partners GP, L.L.C. | 287,900 | $567.2K | 0.00% | −120,000−29.4% | Reduced |
| Vestal Point Capital, LP | 322,671 | $635.7K | 0.07% | +322,671 | New |
| Sofinnova Investments, Inc. | 363,479 | $716.1K | 0.04% | +247,767+214.1% | Added |
| Laurion Capital Management LP | 372,613 | $734.0K | 0.03% | −162,044−30.3% | Reduced |
| State Street Corp | 410,745 | $809.2K | 0.00% | +13,700+3.5% | Added |
| Geode Capital Management, LLC | 529,369 | $1.04M | 0.00% | +12,153+2.3% | Added |
| NEA Management Company, LLC | 570,050 | $1.12M | 0.07% | +388,577+214.1% | Added |
| Artal Group S.A. | 999,513 | $1.97M | 0.07% | −850,000−46.0% | Reduced |
| Verition Fund Management LLC | 1,322,397 | $2.61M | 0.03% | −399,292−23.2% | Reduced |
| Vanguard Group Inc | 1,524,848 | $3.00M | 0.00% | +171,864+12.7% | Added |
| BlackRock Inc. | 1,858,156 | $3.66M | 0.00% | +411,961+28.5% | Added |
| Blue Owl Capital Holdings LP | 1,953,616 | $3.85M | 0.92% | +1,953,616 | New |
| Omega Fund Management, LLC | 2,249,123 | $4.43M | 3.59% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,539,358 | $6.97M | 0.14% | +353,192+11.1% | Added |
| FMR LLC | 4,184,293 | $8.24M | 0.00% | −273,841−6.1% | Reduced |
| BVF Inc | 4,769,164 | $9.40M | 0.24% | +1,600,000+50.5% | Added |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $9.89M | 1.18% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −1,640,000−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −551,010−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −42,916−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −13,094−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −12,687−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −11,176−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,678−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| CHI Advisors LLC | – | – | – | – | Not filed |
| OUP Management Co., LLC | – | – | – | – | Not filed |